Searched for
SHANGHAI FOSUN PHARMACEUTICAL
Fosun to pare stake in Gland PharmaShanghai-based Fosun Pharmaceutical Group, the promoter of Gland Pharma, plans to sell up to a 5% stake in the company through a block deal...- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
- China tech share weakness offsets strength in energy, healthcare stocks; Shanghai Composite Index climbsThe blue-chip CSI300 index fell 0.1 per cent to 4,992.42, but the Shanghai Composite Index rose 0.3 per cent to 3,427.99 points.
- China's Fosun plans plant to make BioNTech's COVID-19 vaccine: CaixinThe first phase of the China-based manufacturing facility will have production capacity of 200 million doses, Caixin said, citing people fa...
- Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland ChinaFosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% ...
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
- China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
- Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
- After Gland, Chinese pharma giant Fosun eyes API maker SymbiotecSymbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.
- CCEA yet to take up Gland Pharma deal with FosunThere have been reports that the CCEA has rejected Chinese firm Shanghai Fosun Pharmaceutical’s proposed $1.3 billion takeover of Indian co...
- FIPB refers Gland Pharma proposal to CCEA for approvalGland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Compa...
- Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
- China stocks slump as report of missing billionaire Guo Guangchang compounds woesThe Hang Seng China Enterprises Index retreated for a seventh day, led by industrial and power companies.
Load More
